Premium
Therapeutic use of erythropoietin in dermatooncology
Author(s) -
Satzger Imke,
Schenck Florian,
Thol Felicitas,
Ganser Arnold,
Kapp Alexander,
Gutzmer Ralf
Publication year - 2007
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/j.1610-0387.2007.06203.x
Subject(s) - erythropoietin , medicine , anemia , chemotherapy , melanoma , epoetin alfa , oncology , cancer , intensive care medicine , cancer research
Summary Erythropoietin has been successfully used in Europe since 1997 in the treatment of anemia induced by chemotherapy of solid tumors. There is only limited experience with regard to its use when treating dermatologic tumors such as metastatic melanoma.We review here current guidelines on the use of erythropoietin in cancer patients and report on our own melanoma patients treated with erythropoietin for chemotherapy‐induced anemia.